Form 4 Filing for Andrew Toy

This filing details stock transactions by Andrew Toy, CEO of CLOVER HEALTH INVESTMENTS, CORP. On April 1, 2026, Mr. Toy acquired 956,307 shares of Class A Common Stock underlying restricted stock units (RSUs) that vest over time, with 25% vesting on April 1, 2027, and the remainder vesting quarterly until April 1, 2030. Additionally, 309,558 shares were automatically withheld to cover taxes due to the vesting of a portion of his RSUs, with a transaction price of $1.76 per share. These withheld shares are part of a larger RSU grant with a final vesting date of January 1, 2027. Following these transactions, Mr. Toy directly holds 10,069,770 shares.